Literature DB >> 34876485

Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre.

Petra Bistrovic1, Sime Manola1,2, Marko Lucijanic3,4.   

Abstract

Entities:  

Keywords:  COVID-19; cardiology; infectious diseases

Mesh：

Substances：

Year:  2021        PMID： 34876485     DOI： 10.1136/postgradmedj-2021-141079

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   4.973


× No keyword cloud information.
  7 in total

1.  Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.

Authors:  Taimoor Ahmed; Samra Haroon Lodhi; Taha Ahmed
Journal:  Cureus       Date:  2022-07-25

2.  Bradyarrhythmia After Remdesivir Administration in SARS-CoV-2: A Review of Literature and Meta-Analysis of Observational Studies in Epidemiology.

Authors:  Safa Al-Jammali; Rana Al-Zakhari; Nicholas Sheets; Arun Mahtani; Veronika Stefanishina; Nidal Isber
Journal:  Cardiol Res       Date:  2022-05-10

3.  Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis.

Authors:  Petra Bistrovic; Sime Manola; Ivan Papic; Ana Jordan; Maja Ortner Hadziabdic; Marko Lucijanic
Journal:  Am J Emerg Med       Date:  2022-05-10       Impact factor: 4.093

4.  Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.

Authors:  Katarzyna Guziejko; Jaroslaw Talalaj; Monika Chorazy; Monika Groth; Anna Moniuszko-Malinowska
Journal:  Infection       Date:  2022-06-14       Impact factor: 7.455

5.  Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19.

Authors:  Giulia Savelloni; Maria Chiara Gatto; Francesca Cancelli; Anna Barbetti; Francesco Cogliati Dezza; Cristiana Franchi; Martina Carnevalini; Gioacchino Galardo; Tommaso Bucci; Maria Alessandroni; Francesco Pugliese; Claudio Maria Mastroianni; Alessandra Oliva
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

6.  Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.

Authors:  Marko Lucijanic; Tomislav Cikara; Petra Bistrovic; Ivan Papic; Maja Ortner Hadziabdic; Nikolina Busic; Marina Lackovic; Natalia Cesar; Valentina Koscak; Josko Mitrovic; Bruno Barsic; Tomo Lucijanic
Journal:  J Infect       Date:  2022-05-02       Impact factor: 38.637

7.  Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.

Authors:  Ioannis Pantazopoulos; Georgios Mavrovounis; Georgios Dimeas; Nikolaos Zikos; Maria Pitsikou; Eleni Rousogianni; Maria Mermiri; Anastasia Michou; Michalis Spanos; Christos Maniotis; Athanasios Chalkias; Eleni Laou; Georgios Zakynthinos; Dimitrios Chatzis; Konstantinos Gourgoulianis
Journal:  Am J Cardiovasc Drugs       Date:  2022-08-25       Impact factor: 3.283
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.